3,253 hedge funds and large institutions have $222B invested in Pfizer in 2021 Q4 according to their latest regulatory filings, with 587 funds opening new positions, 1,251 increasing their positions, 1,152 reducing their positions, and 85 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding in top 10

Funds holding in top 10:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding:

9% more repeat investments, than reductions

Existing positions increased: 1,251 | Existing positions reduced: 1,152

1% more call options, than puts

Call options by funds: $5.34B | Put options by funds: $5.26B

0.97% more ownership

Funds ownership: 66.27%67.24% (+0.97%)

Holders
3,253
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
249
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$5.34B
Puts
$5.26B
Net Calls
Net Calls Change

Top Buyers

1 +$517M
2 +$511M
3 +$381M
4
JP Morgan Chase
JP Morgan Chase
New York
+$314M
5
Two Sigma Advisers
Two Sigma Advisers
New York
+$271M
Name Holding Trade Value Shares
Change
Change in
Stake
2151
$929K
2152
$929K
2153
$928K
2154
$928K
2155
$920K
2156
$919K
2157
$917K
2158
$917K
2159
$915K
2160
$913K
2161
$912K
2162
$912K
2163
$911K
2164
$910K
2165
$909K
2166
$907K
2167
$905K
2168
$903K
2169
$902K
2170
$900K
2171
$899K
2172
$897K
2173
$896K
2174
$895K
2175
$894K